New Guidelines Recommend Routine Iron Screening for Those with Bleeding Disorders

Iron deficiency, prevalent globally, is the most common micronutrient deficiency affecting a significant portion of the world's population. Individuals with bleeding disorders face an increased risk of iron deficiency due to the loss of blood during bleeding episodes, leading to potential long-term health consequences. Recognizing this urgent need, the National Bleeding Disorders Foundation (NBDF) has released pivotal new recommendations aimed at improving healthcare for those with such conditions.

The recommendations issued by NBDF's Medical and Scientific Advisory Council (MASAC) encourage regular screening for iron deficiency and anemia among individuals with inheritable bleeding disorders, regardless of their age, sex, or severity level of their condition. Dr. Glaivy Batsuli, a pediatric hematologist and MASAC member, stated, "Iron deficiency can significantly affect various aspects of an individual’s health and quality of life. Before, we lacked clear guidance, and these new recommendations help fill that essential gap."

The necessity for these guidelines is highlighted by alarming statistics: a report indicated that only 4% of 10,527 women with bleeding disorders had been screened for iron deficiency, yet 72% of this population met the criteria for iron deficiency. This disparity suggests a severe underestimation of the prevalence of iron deficiency within this demographic, underscoring the urgent need for screening protocols.

The document produced by MASAC also emphasizes crucial periods when the risk of iron deficiency is heightened. For instance, for pregnant women with bleeding disorders, it is recommended they undergo screening at least once during the first trimester and again in either the second or third trimester. Postpartum iron deficiency often goes unnoticed yet is associated with complications such as fatigue, depression, and cognitive challenges, which can hinder a mother’s ability to bond with and care for her infant. Therefore, screening is advised after childbirth and again between 6 to 12 weeks postpartum.

Published in March 2026 in the peer-reviewed journal Haemophilia, these guidelines aim to be as inclusive as possible, offering easily accessible information not only for healthcare professionals but also for patients and their families. Dr. Batsuli highlighted, "Our hope is that this information will empower patients to engage more actively in discussions about their health, particularly regarding their iron levels and strategies to enhance their condition."

The NBDF, previously known as the National Hemophilia Foundation, is devoted to discovering cures for inherited blood and bleeding disorders while preventing complications through research, education, and advocacy efforts. Their mission is to support individuals with various bleeding disorders across the United States, including hemophilia, von Willebrand disease, and other rare factor deficiencies. With the new guidelines, the foundation aims to further improve the quality of life for patients facing these challenges, enabling them to thrive in their daily lives.

The release of these recommendations marks a significant development in medical care for individuals with bleeding disorders, and they underscore the importance of proactive health measures, especially for those at heightened risk of iron deficiency. The comprehensive approach that the NBDF has taken not only aims to enhance awareness but also seeks to improve clinical practices surrounding the management of iron deficiency in this vulnerable population.

This initiative serves as a reminder of the critical role that timely screenings and informed healthcare can play in enhancing patient outcomes and overall wellness. As the conversation continues in the medical community, one can only hope that adherence to these recommendations will lead to better health standards for individuals with bleeding disorders and a future where iron deficiency is adequately recognized and managed.